{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:54:37Z","timestamp":1793073277072,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Alexion Pharmaceuticals, Inc."},{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ymgme.2018.12.003","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T13:37:53Z","timestamp":1544103473000},"page":"131-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Final results of the phase 1\/2, open-label clinical study of intravenous recombinant human N-acetyl-\u03b1-d-glucosaminidase (SBC-103) in children with mucopolysaccharidosis IIIB"],"prefix":"10.1016","volume":"126","author":[{"given":"Chester B.","family":"Whitley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Vijay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e9","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff J.M.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Rojas-Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Bubb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran C.","family":"Patki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Escolar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2018.12.003_bb0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ajmg.a.33779","article-title":"Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece","volume":"155A","author":"Heron","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2018.12.003_bb0010","series-title":"Glycosaminoglycans and Mucopolysaccharidosis Type III frontiers in Bioscience","first-page":"1393","volume":"vol. 21","author":"Jakobkiewicz-Banecka","year":"2016"},{"key":"10.1016\/j.ymgme.2018.12.003_bb0015","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2016"},{"key":"10.1016\/j.ymgme.2018.12.003_bb0020","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1523\/JNEUROSCI.3558-04.2004","article-title":"Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum","volume":"24","author":"Cressant","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymgme.2018.12.003_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014192","article-title":"Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease","volume":"5","author":"Malinowska","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2018.12.003_bb0030","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/geno.2001.6552","article-title":"Molecular basis of mucopolysaccharidosis type IIIB in emu (Dromaius novaehollandiae): an avian model of Sanfilippo syndrome type B","volume":"74","author":"Aronovich","year":"2001","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2018.12.003_bb0035","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/gt.2013.14","article-title":"Disease correction by combined neonatal intracranial AAV and systemic lentiviral gene therapy in Sanfilippo Syndrome type B mice","volume":"20","author":"Heldermon","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2018.12.003_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035787","article-title":"Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB","volume":"7","author":"Wilkinson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2018.12.003_bb0045","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/apa.12169","article-title":"Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit\/hyperactivity disorder or autism spectrum disorder","volume":"102","author":"Wijburg","year":"2013","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2018.12.003_bb0050","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0387-7604(01)00242-X","article-title":"Serial magnetic resonance imaging findings in mucopolysaccharidosis IIIB (Sanfilippo's syndrome B)","volume":"23","author":"Zafeiriou","year":"2001","journal-title":"Brain Dev."},{"key":"10.1016\/j.ymgme.2018.12.003_bb0055","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ymgme.2015.12.378","article-title":"Brain MRI patterns in MPS IIIB (Sanfilippo syndrome type B): a longitudinal study","volume":"117","author":"Nestrasil","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.12.003_bb0060","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/TACG.S57672","article-title":"Sanfilippo syndrome: causes, consequences, and treatments","volume":"8","author":"Fedele","year":"2015","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.ymgme.2018.12.003_bb0065","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.ymgme.2013.12.222","article-title":"Intravenous SBC-103, a recombinant human alpha-N-acetylglucosaminidase reduces CNS heparan sulfate content in a mucopolysaccharidosis type IIIB mouse model","volume":"111","author":"Rutkowski","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.12.003_bb0070","series-title":"Vineland Adaptive Behavior Scales, Second Edition (Vineland-II)","author":"Sparrow","year":"2005"},{"key":"10.1016\/j.ymgme.2018.12.003_bb0075","article-title":"Bayley Scales of Infant and Toddler Development","author":"Bayley","year":"2006"},{"key":"10.1016\/j.ymgme.2018.12.003_bb0080","series-title":"Manual for the Kaufman Assessment Battery for Children, Second Edition (KABC-II)","author":"Kaufman","year":"2004"},{"key":"10.1016\/j.ymgme.2018.12.003_bb0085","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ymgme.2016.05.006","article-title":"A phase 1\/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA","volume":"118","author":"Jones","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.12.003_bb0090","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jpeds.2015.11.079","article-title":"A prospective natural history study of mucopolysaccharidosis type IIIA","volume":"170","author":"Shapiro","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2018.12.003_bb0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/8904_2013_269","article-title":"Methods of neurodevelopmental assessment in children with neurodegenerative disease: Sanfilippo syndrome","volume":"13","author":"Delaney","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2018.12.003_bb0100","series-title":"Presented at Annual WORLDSymposium Meeting, San Diego, CA","article-title":"Initial, 24-week results of heparan sulfate levels in cerebrospinal fluid and serum in an open-label, phase I\/II, first-in-human clinical trial of intravenous SBC-103 in mucopolysaccharidosis IIIB [poster LB-33]","author":"Whitley","year":"2016"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2018.12.003_bb0105","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S1090-3798(15)30048-9","article-title":"Brain MRI patterns of disease progression in Sanfilippo syndrome type A (MPS IIIA) [abstract OP47-2274]","volume":"19","author":"Nestrasil","year":"2015","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymgme.2018.12.003_bb0110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ymgme.2016.08.002","article-title":"A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design","volume":"119","author":"Truxal","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.12.003_bb0115","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s40262-014-0173-y","article-title":"Pharmacokinetic and pharmacodynamic evaluation of elosulfase alfa, an enzyme replacement therapy in patients with Morquio A syndrome","volume":"53","author":"Qi","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ymgme.2018.12.003_bb0120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1750-1172-8-42","article-title":"Phase I\/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Sohn","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2018.12.003_bb0125","doi-asserted-by":"crossref","first-page":"14870","DOI":"10.1073\/pnas.1416660111","article-title":"Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB","volume":"111","author":"Kan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671921830492X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671921830492X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T06:37:04Z","timestamp":1565246224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671921830492X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S109671921830492X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.12.003","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Final results of the phase 1\/2, open-label clinical study of intravenous recombinant human N-acetyl-\u03b1-d-glucosaminidase (SBC-103) in children with mucopolysaccharidosis IIIB","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}